Skip Navigation

European Heart Journal 1996 17(Supplement C):26-34; doi:10.1093/eurheartj/17.suppl_C.26
Copyright © 1996 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Josephson, M. E.
Right arrow Articles by Schibgilla, V. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Josephson, M. E.
Right arrow Articles by Schibgilla, V. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 1996 The European Society of Cardiology

Non-pharmacological treatment of supraventricular arrhythmias

M. E. Josephson and V. H. Schibgilla

Clinical Cardiac Electrophysiology Laboratories of the Beth Israel Hospital Boston, MA, U.S.A.

Correspondence: Dr M. E. Josephson, Clinical Cardiac Electrophysiology Laboratories of the Beth Israel Hospital, Boston, MA, U.S.A.

In recent years the recognition of toxicity and relative ineffectiveness of antiarrhythmic drugs in the management of arrhythmias has led to the development of non-pharmacological approaches. In the setting of supraventricular arrhythmias, such non-pharmacological approaches include preventative pacing, atrial defibrillation, surgery and radiofrequency catheter ablation. Success rates for catheter ablation exceeding 90% are expected in A-V nodal reentrant tachycardia, A-V reentry due to concealed or manifest bypass tracts, and incessant atrial tachycardias. Success rates in the management of atrial flutter are rapidly approaching this. Atrial fibrillation remains the main problem for which pharmacological therapy may still be useful. New preventative pacing modes, automatic atrial defibrillation, and perhaps surgical or radiofrequency procedures to limit the ability to sustain atrial fibrillation are on the horizon.

Key Words: Supraventricular tachycardia • electrophysiology • radiofrequency ablation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
R. Ricci, C. Pignalberi, M. Disertori, A. Capucci, L. Padeletti, G. Botto, S. Toscano, F. Miraglia, A. Grammatico, and M. Santini
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias
Eur. Heart J., September 2, 2002; 23(18): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.